United States Biotechnology & Medical Research

Ultragenyx Pharmaceutical Inc (RARE)

Track

Track

Ultragenyx Pharmaceutical Inc. experienced significant insider selling over the past ninety days, totaling approximately $184,035 in net value. Executives, including the CFO and Chief Accounting Officer, offloaded shares amid a 56.2% stock price decline. These transactions occurred following the most recent earnings report, which showed a 29.1% earnings per share beat.
Ticker: RARE Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ultragenyx Pharmaceutical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.8
Huizenga Theodore Alan SVP, Chief Accounting Officer Officer
Transaction date
Sale
Price
156.26
Quantity 33,983 +38.1%
Value US$1,876,446
3.8
THEODORE HUIZENGA Officer Officer
Transaction date
Proposed sale
Price
384.34
Quantity 23,664
Value US$2,025,973
3.8
Huizenga Theodore Alan SVP, Chief Accounting Officer Officer
Transaction date
Sale
Price
460.82
Quantity 21,370 +43.7%
Value US$1,764,129
2.3
Parschauer Karah Herdman EVP and Chief Legal Officer Officer
Transaction date
Sale
Price
24.92
Quantity 1,900 -2.0%
Value US$47,348
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
24.92
Quantity 4,696 -4.6%
Value US$117,024
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
24.92
Quantity 4,696
Value US$117,024
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
33.13
Quantity 4,698 -4.4%
Value US$155,645
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
33.13
Quantity 4,698
Value US$155,645
2.3
Parschauer Karah Herdman EVP and Chief Legal Officer Officer
Transaction date
Sale
Price
24.62
Quantity 1,899 -2.0%
Value US$46,753
2.3
KARAH PARSCHAUER Officer Officer
Transaction date
Proposed sale
Price
24.35
Quantity 3,799
Value US$92,506
2.7
CORAZON D. SANDERS Director Non-Executive Director
Transaction date
Proposed sale
Price
25.05
Quantity 2,000
Value US$50,100
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
23.77
Quantity 4,653 -4.2%
Value US$110,602
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
23.77
Quantity 4,653
Value US$110,602
1.7
SULIMAN SHEHNAAZ Non-Executive Director
Transaction date
Sale
Price
25.12
Quantity 5,740 -17.0%
Value US$144,189
1.7
SHEHNAAZ SULIMAN Director Non-Executive Director
Transaction date
Proposed sale
Price
25.12
Quantity 5,740
Value US$144,189
2.9
Crombez Eric EVP and Chief Medical Officer Officer
Transaction date
Planned sale
Price
24.96
Quantity 344 -0.3%
Value US$8,586
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
24.90
Quantity 4,683 -4.1%
Value US$116,607
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
24.90
Quantity 4,683
Value US$116,607
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
20.97
Quantity 4,683 -5.5%
Value US$98,203
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
20.97
Quantity 4,683 -5.5%
Value US$98,203
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
20.97
Quantity 4,683
Value US$98,203
2.3
KARAH PARSCHAUER Officer Officer
Transaction date
Proposed sale
Price
22.67
Quantity 3,508
Value US$79,526
2.3
Parschauer Karah Herdman EVP and Chief Legal Officer Officer
Transaction date
Sale
Price
22.67
Quantity 3,508 -5.0%
Value US$79,526
2.3
Parschauer Karah Herdman EVP and Chief Legal Officer Officer
Transaction date
Sale
Price
21.40
Quantity 6,018 -7.9%
Value US$128,785
2.3
KARAH PARSCHAUER Officer Officer
Transaction date
Proposed sale
Price
21.40
Quantity 6,018
Value US$128,775
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
22.40
Quantity 1,635 -1.9%
Value US$36,624
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
22.40
Quantity 1,635
Value US$36,624
4.0
Pinion John Richard See Remarks Officer
Transaction date
Planned sale
Price
22.80
Quantity 10,029 -8.4%
Value US$228,661
3.5
Harris Erik EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
22.80
Quantity 10,539 -10.5%
Value US$240,289
3.0
KAKKIS EMIL D President & CEO Executive Director
Transaction date
Planned sale
Price
22.80
Quantity 54,404 -7.6%
Value US$1,240,411
3.8
Huizenga Theodore Alan SVP, Chief Accounting Officer Officer
Transaction date
Sale
Price
22.80
Quantity 1,632 -3.2%
Value US$37,210
2.3
Parschauer Karah Herdman EVP and Chief Legal Officer Officer
Transaction date
Planned sale
Price
22.80
Quantity 8,135 -9.6%
Value US$185,478
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
22.54
Quantity 3,119 -3.5%
Value US$70,302
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
22.80
Quantity 5,290 -5.6%
Value US$120,612
2.9
Crombez Eric EVP and Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.80
Quantity 7,029 -8.4%
Value US$160,261
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
22.54
Quantity 3,119
Value US$70,302
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
23.56
Quantity 3,061 -3.3%
Value US$72,117
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
23.56
Quantity 3,061
Value US$72,117
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
22.84
Quantity 3,150 -3.3%
Value US$71,946
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
22.84
Quantity 3,150
Value US$71,946
3.8
Huizenga Theodore Alan SVP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
34.38
Quantity 85 -0.2%
Value US$2,922
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
36.38
Quantity 3,081 -3.1%
Value US$112,087
3.5
HOWARD HORN Officer Officer
Transaction date
Proposed sale
Price
36.38
Quantity 3,081
Value US$112,087
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
31.51
Quantity 7,942 -7.5%
Value US$250,252
3.8
Huizenga Theodore Alan SVP, Chief Accounting Officer Officer
Transaction date
Sale
Price
29.17
Quantity 64 -0.1%
Value US$1,867
2.3
KARAH PARSCHAUER Officer Officer
Transaction date
Proposed sale
Price
31.17
Quantity 2,450
Value US$76,366
2.3
Parschauer Karah Herdman EVP and Chief Legal Officer Officer
Transaction date
Planned sale
Price
31.17
Quantity 2,450 -3.2%
Value US$76,366
3.8
Huizenga Theodore Alan SVP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
31.39
Quantity 84 -0.2%
Value US$2,637
2.7
Sanders Corazon (Corsee) D. Non-Executive Director
Transaction date
Sale
Price
37.39
Quantity 2,405 -13.6%
Value US$89,923
2.7
CORAZON D. SANDERS Director Non-Executive Director
Transaction date
Proposed sale
Price
37.39
Quantity 2,405
Value US$89,923
2.9
Crombez Eric EVP and Chief Medical Officer Officer
Transaction date
Planned sale
Price
39.24
Quantity 520 -0.7%
Value US$20,405
2.9
Crombez Eric EVP and Chief Medical Officer Officer
Transaction date
Sale
Price
35.11
Quantity 242 -0.3%
Value US$8,497
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
40.40
Quantity 1,785 -1.7%
Value US$72,114
2.9
Crombez Eric EVP and Chief Medical Officer Officer
Transaction date
Planned sale
Price
42.10
Quantity 8,945 -11.1%
Value US$376,584
3.0
KAKKIS EMIL D President & CEO Executive Director
Transaction date
Sale
Price
42.10
Quantity 73,434 -10.3%
Value US$3,091,571
4.0
Pinion John Richard See Remarks Officer
Transaction date
Sale
Price
42.10
Quantity 14,439 -11.8%
Value US$607,882
2.3
Parschauer Karah Herdman EVP and Chief Legal Officer Officer
Transaction date
Sale
Price
42.10
Quantity 12,846 -14.6%
Value US$540,817
3.5
Harris Erik EVP & Chief Commercial Officer Officer
Transaction date
Planned sale
Price
42.10
Quantity 15,103 -14.7%
Value US$635,836
3.8
Huizenga Theodore Alan SVP, Chief Accounting Officer Officer
Transaction date
Sale
Price
42.10
Quantity 967 -1.9%
Value US$40,711
3.0
KAKKIS EMIL D President & CEO Executive Director
Transaction date
Sale
Price
42.48
Quantity 25,000 -1.1%
Value US$1,062,000
3.0
KAKKIS EMIL D Officer Officer
Transaction date
Proposed sale
Price
42.48
Quantity 25,000
Value US$1,062,100
2.3
Parschauer Karah Herdman EVP and Chief Legal Officer Officer
Transaction date
Sale
Price
42.75
Quantity 760 -1.4%
Value US$32,490
2.3
Parschauer Karah Herdman EVP and Chief Legal Officer Officer
Transaction date
Sale
Price
42.93
Quantity 2,230 -3.8%
Value US$95,734
2.3
Parschauer Karah Herdman Officer Officer
Transaction date
Proposed sale
Price
42.88
Quantity 2,990
Value US$128,215
3.0
KAKKIS EMIL D President & CEO Executive Director
Transaction date
Sale
Price
42.23
Quantity 11,727 -0.5%
Value US$495,231
3.0
KAKKIS EMIL D Officer Officer
Transaction date
Proposed sale
Price
42.23
Quantity 11,727
Value US$495,264
3.0
KAKKIS EMIL D President & CEO Executive Director
Transaction date
Sale
Price
50.00
Quantity 8,273 -0.4%
Value US$413,650
3.0
KAKKIS EMIL D Officer Officer
Transaction date
Proposed sale
Price
50.00
Quantity 8,273
Value US$413,650
3.5
Horn Howard Chief Financial Officer Officer
Transaction date
Sale
Price
52.76
Quantity 7,465 -7.5%
Value US$393,853
3.8
Huizenga Theodore Alan SVP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
56.19
Quantity 91 -0.2%
Value US$5,113
3.0
KAKKIS EMIL D President & CEO Executive Director
Transaction date
Sale
Price
55.85
Quantity 20,000 -0.9%
Value US$1,117,000
3.0
KAKKIS EMIL D Officer Officer
Transaction date
Proposed sale
Price
55.85
Quantity 20,000
Value US$1,117,096
3.0
KAKKIS EMIL D President & CEO Executive Director
Transaction date
Sale
Price
50.17
Quantity 20,000 -0.9%
Value US$1,003,400
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-15 2026-09-15 S Sale
3.8
Huizenga Theodore Alan

SVP, Chief Accounting Officer

Officer
33,983 +38.1%
156.26
US$1,876,446 		33,983 +38.1% 156.26 US$1,876,446
2026-09-15 2026-09-15 PrS Proposed sale
3.8
THEODORE HUIZENGA

Officer

Officer
23,664
384.34
US$2,025,973 		23,664 384.34 US$2,025,973
2026-09-08 2026-09-03 S Sale
3.8
Huizenga Theodore Alan

SVP, Chief Accounting Officer

Officer
21,370 +43.7%
460.82
US$1,764,129 		21,370 +43.7% 460.82 US$1,764,129
2026-08-04 2026-08-03 S Sale
2.3
Parschauer Karah Herdman

EVP and Chief Legal Officer

Officer
1,900 -2.0%
24.92
US$47,348 		1,900 -2.0% 24.92 US$47,348
2026-08-04 2026-08-03 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
4,696 -4.6%
24.92
US$117,024 		4,696 -4.6% 24.92 US$117,024
2026-08-03 2026-08-03 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
4,696
24.92
US$117,024 		4,696 24.92 US$117,024
2026-07-06 2026-07-01 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
4,698 -4.4%
33.13
US$155,645 		4,698 -4.4% 33.13 US$155,645
2026-07-01 2026-07-01 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
4,698
33.13
US$155,645 		4,698 33.13 US$155,645
2026-06-15 2026-06-15 S Sale
2.7
Sanders Corazon (Corsee) D.
Non-Executive Director
2,000 -8.7%
25.05
US$50,100 		2,000 -8.7% 25.05 US$50,100
2026-06-15 2026-06-15 S Sale
2.3
Parschauer Karah Herdman

EVP and Chief Legal Officer

Officer
1,899 -2.0%
24.62
US$46,753 		1,899 -2.0% 24.62 US$46,753
2026-06-15 2026-06-15 PrS Proposed sale
2.3
KARAH PARSCHAUER

Officer

Officer
3,799
24.35
US$92,506 		3,799 24.35 US$92,506
2026-06-15 2026-06-15 PrS Proposed sale
2.7
CORAZON D. SANDERS

Director

Non-Executive Director
2,000
25.05
US$50,100 		2,000 25.05 US$50,100
2026-06-01 2026-06-01 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
4,653 -4.2%
23.77
US$110,602 		4,653 -4.2% 23.77 US$110,602
2026-06-01 2026-06-01 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
4,653
23.77
US$110,602 		4,653 23.77 US$110,602
2026-05-18 2026-05-18 S Sale
1.7
SULIMAN SHEHNAAZ
Non-Executive Director
5,740 -17.0%
25.12
US$144,189 		5,740 -17.0% 25.12 US$144,189
2026-05-18 2026-05-18 PrS Proposed sale
1.7
SHEHNAAZ SULIMAN

Director

Non-Executive Director
5,740
25.12
US$144,189 		5,740 25.12 US$144,189
2026-05-06 2026-05-05 PlS Planned sale
2.9
Crombez Eric

EVP and Chief Medical Officer

Officer
344 -0.3%
24.96
US$8,586 		344 -0.3% 24.96 US$8,586
2026-05-04 2026-05-01 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
4,683 -4.1%
24.90
US$116,607 		4,683 -4.1% 24.90 US$116,607
2026-05-01 2026-05-01 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
4,683
24.90
US$116,607 		4,683 24.90 US$116,607
2026-04-02 2026-04-01 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
4,683 -5.5%
20.97
US$98,203 		4,683 -5.5% 20.97 US$98,203
2026-04-02 2026-04-01 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
4,683 -5.5%
20.97
US$98,203 		4,683 -5.5% 20.97 US$98,203
2026-04-01 2026-04-01 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
4,683
20.97
US$98,203 		4,683 20.97 US$98,203
2026-03-10 2026-03-10 PrS Proposed sale
2.3
KARAH PARSCHAUER

Officer

Officer
3,508
22.67
US$79,526 		3,508 22.67 US$79,526
2026-03-10 2026-03-10 S Sale
2.3
Parschauer Karah Herdman

EVP and Chief Legal Officer

Officer
3,508 -5.0%
22.67
US$79,526 		3,508 -5.0% 22.67 US$79,526
2026-03-10 2026-03-06 S Sale
2.3
Parschauer Karah Herdman

EVP and Chief Legal Officer

Officer
6,018 -7.9%
21.40
US$128,785 		6,018 -7.9% 21.40 US$128,785
2026-03-06 2026-03-06 PrS Proposed sale
2.3
KARAH PARSCHAUER

Officer

Officer
6,018
21.40
US$128,775 		6,018 21.40 US$128,775
2026-03-03 2026-03-03 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
1,635 -1.9%
22.40
US$36,624 		1,635 -1.9% 22.40 US$36,624
2026-03-03 2026-03-03 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
1,635
22.40
US$36,624 		1,635 22.40 US$36,624
2026-03-03 2026-03-02 PlS Planned sale
4.0
Pinion John Richard

See Remarks

Officer
10,029 -8.4%
22.80
US$228,661 		10,029 -8.4% 22.80 US$228,661
2026-03-03 2026-03-02 PlS Planned sale
3.5
Harris Erik

EVP & Chief Commercial Officer

Officer
10,539 -10.5%
22.80
US$240,289 		10,539 -10.5% 22.80 US$240,289
2026-03-03 2026-03-02 PlS Planned sale
3.0
KAKKIS EMIL D

President & CEO

Executive Director
54,404 -7.6%
22.80
US$1,240,411 		54,404 -7.6% 22.80 US$1,240,411
2026-03-03 2026-03-02 S Sale
3.8
Huizenga Theodore Alan

SVP, Chief Accounting Officer

Officer
1,632 -3.2%
22.80
US$37,210 		1,632 -3.2% 22.80 US$37,210
2026-03-03 2026-03-02 PlS Planned sale
2.3
Parschauer Karah Herdman

EVP and Chief Legal Officer

Officer
8,135 -9.6%
22.80
US$185,478 		8,135 -9.6% 22.80 US$185,478
2026-03-03 2026-03-02 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
3,119 -3.5%
22.54
US$70,302 		3,119 -3.5% 22.54 US$70,302
2026-03-03 2026-03-02 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
5,290 -5.6%
22.80
US$120,612 		5,290 -5.6% 22.80 US$120,612
2026-03-03 2026-03-02 PlS Planned sale
2.9
Crombez Eric

EVP and Chief Medical Officer

Officer
7,029 -8.4%
22.80
US$160,261 		7,029 -8.4% 22.80 US$160,261
2026-03-02 2026-03-02 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
3,119
22.54
US$70,302 		3,119 22.54 US$70,302
2026-02-03 2026-02-02 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
3,061 -3.3%
23.56
US$72,117 		3,061 -3.3% 23.56 US$72,117
2026-02-02 2026-02-02 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
3,061
23.56
US$72,117 		3,061 23.56 US$72,117
2026-01-05 2026-01-02 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
3,150 -3.3%
22.84
US$71,946 		3,150 -3.3% 22.84 US$71,946
2026-01-02 2026-01-02 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
3,150
22.84
US$71,946 		3,150 22.84 US$71,946
2025-12-30 2025-12-29 PlS Planned sale
3.8
Huizenga Theodore Alan

SVP, Chief Accounting Officer

Officer
85 -0.2%
34.38
US$2,922 		85 -0.2% 34.38 US$2,922
2025-12-11 2025-12-10 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
3,081 -3.1%
36.38
US$112,087 		3,081 -3.1% 36.38 US$112,087
2025-12-10 2025-12-10 PrS Proposed sale
3.5
HOWARD HORN

Officer

Officer
3,081
36.38
US$112,087 		3,081 36.38 US$112,087
2025-10-14 2025-10-13 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
7,942 -7.5%
31.51
US$250,252 		7,942 -7.5% 31.51 US$250,252
2025-09-19 2025-09-18 S Sale
3.8
Huizenga Theodore Alan

SVP, Chief Accounting Officer

Officer
64 -0.1%
29.17
US$1,867 		64 -0.1% 29.17 US$1,867
2025-09-12 2025-09-12 PrS Proposed sale
2.3
KARAH PARSCHAUER

Officer

Officer
2,450
31.17
US$76,366 		2,450 31.17 US$76,366
2025-09-12 2025-09-12 PlS Planned sale
2.3
Parschauer Karah Herdman

EVP and Chief Legal Officer

Officer
2,450 -3.2%
31.17
US$76,366 		2,450 -3.2% 31.17 US$76,366
2025-09-08 2025-09-05 PlS Planned sale
3.8
Huizenga Theodore Alan

SVP, Chief Accounting Officer

Officer
84 -0.2%
31.39
US$2,637 		84 -0.2% 31.39 US$2,637
2025-06-23 2025-06-20 S Sale
2.7
Sanders Corazon (Corsee) D.
Non-Executive Director
2,405 -13.6%
37.39
US$89,923 		2,405 -13.6% 37.39 US$89,923
2025-06-20 2025-06-20 PrS Proposed sale
2.7
CORAZON D. SANDERS

Director

Non-Executive Director
2,405
37.39
US$89,923 		2,405 37.39 US$89,923
2025-05-05 2025-05-05 PlS Planned sale
2.9
Crombez Eric

EVP and Chief Medical Officer

Officer
520 -0.7%
39.24
US$20,405 		520 -0.7% 39.24 US$20,405
2025-05-05 2025-04-21 S Sale
2.9
Crombez Eric

EVP and Chief Medical Officer

Officer
242 -0.3%
35.11
US$8,497 		242 -0.3% 35.11 US$8,497
2025-03-10 2025-03-06 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
1,785 -1.7%
40.40
US$72,114 		1,785 -1.7% 40.40 US$72,114
2025-03-04 2025-03-03 S Sale
2.5
Kassberg Thomas Richard

CBO & EVP

Officer
6,028 -2.2%
42.10
US$253,779 		6,028 -2.2% 42.10 US$253,779
2025-03-04 2025-03-03 PlS Planned sale
2.9
Crombez Eric

EVP and Chief Medical Officer

Officer
8,945 -11.1%
42.10
US$376,584 		8,945 -11.1% 42.10 US$376,584
2025-03-04 2025-03-03 S Sale
3.0
KAKKIS EMIL D

President & CEO

Executive Director
73,434 -10.3%
42.10
US$3,091,571 		73,434 -10.3% 42.10 US$3,091,571
2025-03-04 2025-03-03 S Sale
4.0
Pinion John Richard

See Remarks

Officer
14,439 -11.8%
42.10
US$607,882 		14,439 -11.8% 42.10 US$607,882
2025-03-04 2025-03-03 S Sale
2.3
Parschauer Karah Herdman

EVP and Chief Legal Officer

Officer
12,846 -14.6%
42.10
US$540,817 		12,846 -14.6% 42.10 US$540,817
2025-03-04 2025-03-03 PlS Planned sale
3.5
Harris Erik

EVP & Chief Commercial Officer

Officer
15,103 -14.7%
42.10
US$635,836 		15,103 -14.7% 42.10 US$635,836
2025-03-04 2025-03-03 S Sale
3.8
Huizenga Theodore Alan

SVP, Chief Accounting Officer

Officer
967 -1.9%
42.10
US$40,711 		967 -1.9% 42.10 US$40,711
2025-03-04 2025-02-28 S Sale
3.0
KAKKIS EMIL D

President & CEO

Executive Director
25,000 -1.1%
42.48
US$1,062,000 		25,000 -1.1% 42.48 US$1,062,000
2025-02-28 2025-02-28 PrS Proposed sale
3.0
KAKKIS EMIL D

Officer

Officer
25,000
42.48
US$1,062,100 		25,000 42.48 US$1,062,100
2025-03-03 2025-02-27 S Sale
2.3
Parschauer Karah Herdman

EVP and Chief Legal Officer

Officer
760 -1.4%
42.75
US$32,490 		760 -1.4% 42.75 US$32,490
2025-03-03 2025-02-27 S Sale
2.3
Parschauer Karah Herdman

EVP and Chief Legal Officer

Officer
2,230 -3.8%
42.93
US$95,734 		2,230 -3.8% 42.93 US$95,734
2025-02-27 2025-02-27 PrS Proposed sale
2.3
Parschauer Karah Herdman

Officer

Officer
2,990
42.88
US$128,215 		2,990 42.88 US$128,215
2024-12-31 2024-12-30 S Sale
3.0
KAKKIS EMIL D

President & CEO

Executive Director
11,727 -0.5%
42.23
US$495,231 		11,727 -0.5% 42.23 US$495,231
2024-12-30 2024-12-30 PrS Proposed sale
3.0
KAKKIS EMIL D

Officer

Officer
11,727
42.23
US$495,264 		11,727 42.23 US$495,264
2024-12-11 2024-12-10 S Sale
3.0
KAKKIS EMIL D

President & CEO

Executive Director
8,273 -0.4%
50.00
US$413,650 		8,273 -0.4% 50.00 US$413,650
2024-12-10 2024-12-10 PrS Proposed sale
3.0
KAKKIS EMIL D

Officer

Officer
8,273
50.00
US$413,650 		8,273 50.00 US$413,650
2024-10-11 2024-10-10 S Sale
3.5
Horn Howard

Chief Financial Officer

Officer
7,465 -7.5%
52.76
US$393,853 		7,465 -7.5% 52.76 US$393,853
2024-09-05 2024-09-03 PlS Planned sale
3.8
Huizenga Theodore Alan

SVP, Chief Accounting Officer

Officer
91 -0.2%
56.19
US$5,113 		91 -0.2% 56.19 US$5,113
2024-09-05 2024-09-03 S Sale
3.0
KAKKIS EMIL D

President & CEO

Executive Director
20,000 -0.9%
55.85
US$1,117,000 		20,000 -0.9% 55.85 US$1,117,000
2024-09-03 2024-09-03 PrS Proposed sale
3.0
KAKKIS EMIL D

Officer

Officer
20,000
55.85
US$1,117,096 		20,000 55.85 US$1,117,096
2024-08-07 2024-08-06 S Sale
3.0
KAKKIS EMIL D

President & CEO

Executive Director
20,000 -0.9%
50.17
US$1,003,400 		20,000 -0.9% 50.17 US$1,003,400
Explore more

More insider trading research around Ultragenyx Pharmaceutical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America